On January 3, 2025, David H.Y. Ho, a member of the Board of Directors (the “Board”) of Qorvo, Inc. (the “Company”) informed the Company of his decision not to stand for reelection and to retire from the Board upon the expiration of his term at the Company’s 2025 Annual Meeting of Stockholders.
On January 8, 2025, our Board of Directors (the “Board”) authorized an increase in the size of the Board to six members and appointed Joshua M. Moss to serve on the Board as an independent director.
On January 7, 2025, the Board of Directors (the “ Board ”) of US Foods Holding Corp. (the “ Company ”) increased the size of the Board to nine directors and appointed David W. Bullock to the Board and the Nominating and Corporate Governance Committee.
On January 6, 2025, the Board of Directors (the “Board”) of Heritage Distilling Holding Company, Inc. (the “Company”) increased the size of the Board to eight directors and appointed Matthew J. Swann to serve as a director of the Company, effective immediately.
On January 8, 2025, Mr. Michael Bingle notified the Board of Directors of the Company of his resignation from service as a director of the Company, effective January 13, 2025.
On January 9, 2025, the Board of Directors (the “Board”) of Portillo’s Inc. (the “Company”) elected Jack Hartung to serve on the Board, effective immediately.
On January 6, 2025, Bhavesh (Bob) V. Patel notified the Board of Directors that he has decided to not stand for re-election as a Director of Halliburton Company and retire early from serving as a Director of Halliburton Company to pursue other opportunities.
On January 8, 2025, Winnebago Industries, Inc. (the “Company”) announced the appointment of Michael E. Pack to its Board of Directors (“Board”) effective January 8, 2025.
Appointed
Candice Todd
Member of the Special Committee related to the National HealthCare Corporation potential lease
On January 6, 2025, consistent with the foregoing, Mr. Roedel informed the Company of his resignation from the Company’s Board of Directors, effective immediately.
Farmers & Merchants Bancorp announced today that Calvin (“Kelly”) Suess, the Company’s longest serving current member of the Board of Directors, has tendered his resignation effective at the next Board of Directors Meeting to be held on January 14, 2025 after having served on the board for 35 years.
Departed
Jeh C. Johnson
Director
UNITED STATES STEEL CORP
Effective
2025-01-07
Filed
January 8, 2025, 6:59 PM ET
On January 7, 2025, Jeh C. Johnson notified United States Steel Corporation (the “Company”) that he was resigning from the Company’s Board of Directors, effective immediately.
On January 6, 2025, the Board of Directors (the “Board”) of SolarEdge Technologies, Inc. (the “Company”) increased the size of the Company’s Board from 8 to 10 directors and appointed Mr. Gilad Almogy and Mr. Yoram Teitz to the Board as Class I directors to fill these vacancies, effective immediately, and to serve until the Company’s 2025 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal.
On January 6, 2025, the Board of Directors (the “Board”) of SolarEdge Technologies, Inc. (the “Company”) increased the size of the Company’s Board from 8 to 10 directors and appointed Mr. Gilad Almogy and Mr. Yoram Teitz to the Board as Class I directors to fill these vacancies, effective immediately, and to serve until the Company’s 2025 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal.
Departed
John Schmid
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Rafael Amado
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Marcea Lloyd
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Luke Corning
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Appointed
Roger Brown
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
the directors of Merger Sub as of immediately prior to the Effective Time, Sean A. Johnston and Roger Brown, became the directors of the Company
Appointed
Sean A. Johnston
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
the directors of Merger Sub as of immediately prior to the Effective Time, Sean A. Johnston and Roger Brown, became the directors of the Company
Departed
Mark Gergen
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Cynthia Collins
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Kristin Yarema
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Charles Baum
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
On January 6, 2025 the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”) increased the size of the Board from seven to eight members and appointed Erez Kalir to fill the resulting vacancy, to serve on the Board as an independent Class III director until the Company’s 2027 annual meeting of stockholders and until his successor is duly elected and qualified.
On January 2, 2025, Ford Tamer notified the Board of Directors (the “Board”) of Teradyne, Inc. (“Teradyne”) of his decision not to stand for re-election at Teradyne’s next annual meeting of shareholders, expected to be held in May 2025
Effective as of January 7, 2025, the Board increased the size of the Board from five (5) directors to seven (7) directors and appointed Mr. Sloane to the Board
Also on January 6, 2025, Wong Kok Seong and Doris Wong Sing Ee each resigned from their positions as Independent Director of the Company, effective immediately.
Also on January 6, 2025, Wong Kok Seong and Doris Wong Sing Ee each resigned from their positions as Independent Director of the Company, effective immediately.
The terms of Beth H. Harwell and Brian E. Noland as members of the Tennessee Valley Authority ("TVA") Board of Directors ended January 3, 2025, with the adjournment of the most recent session of Congress.
The terms of Beth H. Harwell and Brian E. Noland as members of the Tennessee Valley Authority ("TVA") Board of Directors ended January 3, 2025, with the adjournment of the most recent session of Congress.
On January 3, 2025, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Joseph D. Kava as a member of the Board, effective January 3, 2025.
On January 2, 2025, Freddie Mac (formally the Federal Home Loan Mortgage Corporation) elected Jane E. Prokop to its Board of Directors (the Board), effective as of January 2, 2025.
Appointed
Todd P. Branning
Director
NeuBase Therapeutics, Inc.
Effective
2025-01-04
Filed
January 7, 2025, 6:59 PM ET
On January 4, 2025, Mr. Branning was appointed to the Board of Directors of the Company (the “Board”).
Departed
Dov A. Goldstein
Director
NeuBase Therapeutics, Inc.
Effective
2025-01-04
Filed
January 7, 2025, 6:59 PM ET
On January 4, 2025, Dov A. Goldstein, M.D. notified the Company of his resignation as a member of the Board, effective immediately.
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.